BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,039 | -22.3% | 5,496,577 | -2.3% | 0.04% | -20.0% |
| Q2 2023 | $355,399 | +59.6% | 5,623,376 | +13.6% | 0.05% | +51.5% |
| Q1 2023 | $222,631 | +18.2% | 4,948,434 | +15.1% | 0.03% | +10.0% |
| Q4 2022 | $188,352 | -99.9% | 4,299,290 | +6.6% | 0.03% | -31.8% |
| Q3 2022 | $265,657,000 | -6.6% | 4,031,811 | -28.4% | 0.04% | +22.2% |
| Q2 2022 | $284,457,000 | -9.7% | 5,631,687 | +14.2% | 0.04% | +12.5% |
| Q1 2022 | $315,128,000 | -35.3% | 4,933,125 | +8.4% | 0.03% | -27.3% |
| Q4 2021 | $487,408,000 | +8.4% | 4,550,539 | +4.1% | 0.04% | +4.8% |
| Q3 2021 | $449,468,000 | +19.9% | 4,371,828 | +2.6% | 0.04% | +20.0% |
| Q2 2021 | $374,896,000 | -4.8% | 4,262,114 | +5.3% | 0.04% | -10.3% |
| Q1 2021 | $393,711,000 | -4.8% | 4,049,274 | +9.8% | 0.04% | -7.1% |
| Q4 2020 | $413,583,000 | +25.1% | 3,687,766 | +3.4% | 0.04% | +10.5% |
| Q3 2020 | $330,606,000 | +18.1% | 3,566,406 | -0.7% | 0.04% | +8.6% |
| Q2 2020 | $280,011,000 | +33.5% | 3,589,884 | +0.1% | 0.04% | +6.1% |
| Q1 2020 | $209,715,000 | -21.9% | 3,586,091 | +6.9% | 0.03% | -5.7% |
| Q4 2019 | $268,654,000 | +1.3% | 3,353,567 | -7.1% | 0.04% | -7.9% |
| Q3 2019 | $265,316,000 | -23.6% | 3,611,213 | -1.9% | 0.04% | -22.4% |
| Q2 2019 | $347,256,000 | +28.5% | 3,681,291 | +9.1% | 0.05% | +22.5% |
| Q1 2019 | $270,218,000 | +65.9% | 3,375,609 | +11.7% | 0.04% | +42.9% |
| Q4 2018 | $162,922,000 | -27.6% | 3,022,107 | +4.8% | 0.03% | -15.2% |
| Q3 2018 | $225,152,000 | +13.6% | 2,884,347 | -7.6% | 0.03% | +10.0% |
| Q2 2018 | $198,205,000 | -37.7% | 3,122,318 | -10.0% | 0.03% | -41.2% |
| Q1 2018 | $318,068,000 | +27.5% | 3,468,567 | +4.8% | 0.05% | +27.5% |
| Q4 2017 | $249,562,000 | +30.4% | 3,309,402 | +20.5% | 0.04% | +21.2% |
| Q3 2017 | $191,394,000 | +52.7% | 2,747,158 | +11.0% | 0.03% | +43.5% |
| Q2 2017 | $125,357,000 | +55.6% | 2,473,985 | +22.8% | 0.02% | +53.3% |
| Q1 2017 | $80,566,000 | +288.4% | 2,014,649 | +172.4% | 0.02% | +275.0% |
| Q4 2016 | $20,743,000 | +97.7% | 739,502 | +109.4% | 0.00% | +100.0% |
| Q3 2016 | $10,490,000 | -12.9% | 353,194 | -40.6% | 0.00% | -33.3% |
| Q2 2016 | $12,048,000 | +30.4% | 594,983 | +16.3% | 0.00% | +50.0% |
| Q1 2016 | $9,238,000 | -34.3% | 511,808 | -4.1% | 0.00% | -33.3% |
| Q4 2015 | $14,062,000 | +32.3% | 533,848 | +7.2% | 0.00% | +50.0% |
| Q3 2015 | $10,630,000 | -20.3% | 498,149 | -1.1% | 0.00% | -33.3% |
| Q2 2015 | $13,339,000 | – | 503,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |